H.R. 6509
This bill provides for increased oversight of drug compounding and imposes statutory limits on compounded drugs that are essentially copies of commercially available drugs.
Learn about this bill’s status and read its full summary in the Pocket Congress app.
Scan to open this page in Pocket Congress